AAAAAA

   
Results: 1-8 |
Results: 8
4,5-DIPHENYL-2-OXAZOLYL)-5-OXAZOLYL]PHENOXY]ACETIC ACID (BMY-45778) IS A POTENT NONPROSTANOID PROSTACYCLIN PARTIAL AGONIST - EFFECTS ON PLATELET-AGGREGATION, ADENYLYL-CYCLASE, CAMP LEVELS, PROTEIN-KINASE, AND ILOPROST BINDING
Authors: SEILER SM BRASSARD CL FEDERICI ME ROMINE J MEANWELL NA
Citation: Sm. Seiler et al., 4,5-DIPHENYL-2-OXAZOLYL)-5-OXAZOLYL]PHENOXY]ACETIC ACID (BMY-45778) IS A POTENT NONPROSTANOID PROSTACYCLIN PARTIAL AGONIST - EFFECTS ON PLATELET-AGGREGATION, ADENYLYL-CYCLASE, CAMP LEVELS, PROTEIN-KINASE, AND ILOPROST BINDING, Prostaglandins, 53(1), 1997, pp. 21-35
COMBINATION THERAPY WITH STAVUDINE AND DIDANOSINE IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - PHARMACOKINETIC PROPERTIES, SAFETY, AND IMMUNOLOGICAL AND VIROLOGICAL EFFECTS
Authors: KLINE MW FLETCHER CV FEDERICI ME HARRIS AT EVANS KD RUTKIEWICZ VL SHEARER WT DUNKLE LM
Citation: Mw. Kline et al., COMBINATION THERAPY WITH STAVUDINE AND DIDANOSINE IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - PHARMACOKINETIC PROPERTIES, SAFETY, AND IMMUNOLOGICAL AND VIROLOGICAL EFFECTS, Pediatrics, 97(6), 1996, pp. 886-890
COMBINATION THERAPY WITH STAVUDINE (D4T) AND DIDANOSINE (DDI) IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
Authors: KLINE MW FLETCHER CV FEDERICI ME HARRIS AT EVANS KD RUTKIEWICZ VL SHEARER WT DUNKLE LM
Citation: Mw. Kline et al., COMBINATION THERAPY WITH STAVUDINE (D4T) AND DIDANOSINE (DDI) IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION, Pediatric research, 39(4), 1996, pp. 1039-1039
A PHASE I II EVALUATION OF STAVUDINE (D4T) IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/
Authors: KLINE MW DUNKLE LM CHURCH JA GOLDSMITH JC HARRIS AT FEDERICI ME SCHULTZE ME WOODS L LOEWEN DF KAUL S CROSS A RUTKIEWICZ VL ROSENBLATT HM HANSON IC SHEARER WT
Citation: Mw. Kline et al., A PHASE I II EVALUATION OF STAVUDINE (D4T) IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/, Pediatrics, 96(2), 1995, pp. 247-252
2-[3-[2-(4,5-DIPHENYL-2-OXAZOLYL)ETHYL]PHENOXY] ACETIC-ACID (BMY-42393) - A NEW, STRUCTURALLY-NOVEL PROSTACYCLIN PARTIAL AGONIST .1. INHIBITION OF PLATELET-AGGREGATION AND MECHANISM OF ACTION
Authors: SEILER SM BRASSARD CL FEDERICI ME BUCHANAN JO ZAVOICO GB FLEMING JS MEANWELL NA
Citation: Sm. Seiler et al., 2-[3-[2-(4,5-DIPHENYL-2-OXAZOLYL)ETHYL]PHENOXY] ACETIC-ACID (BMY-42393) - A NEW, STRUCTURALLY-NOVEL PROSTACYCLIN PARTIAL AGONIST .1. INHIBITION OF PLATELET-AGGREGATION AND MECHANISM OF ACTION, Thrombosis research, 74(2), 1994, pp. 115-123
GENOTYPIC AND PHENOTYPIC ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES FROM PATIENTS ON PROLONGED STAVUDINE THERAPY
Authors: LIN PF SAMANTA H ROSE RE PATICK AK TRIMBLE J BECHTOLD CM REVIE DR KHAN NC FEDERICI ME LI H LEE A ANDERSON RE COLONNO RJ
Citation: Pf. Lin et al., GENOTYPIC AND PHENOTYPIC ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES FROM PATIENTS ON PROLONGED STAVUDINE THERAPY, The Journal of infectious diseases, 170(5), 1994, pp. 1157-1164
NONPROSTANOID PROSTACYCLIN MIMETICS .4. DERIVATIVES OF 3-[2-(4,5-DIPHENYL-2-OXAZOLYL)ETHYL]PHENOXY]ACETIC ACID SUBSTITUTED-ALPHA TO THE OXAZOLE RING
Authors: MEANWELL NA ROSENFELD MJ WRIGHT JJK BRASSARD CL BUCHANAN JO FEDERICI ME FLEMING JS GAMBERDELLA M HARTL KS ZAVOICO GB SEILER SM
Citation: Na. Meanwell et al., NONPROSTANOID PROSTACYCLIN MIMETICS .4. DERIVATIVES OF 3-[2-(4,5-DIPHENYL-2-OXAZOLYL)ETHYL]PHENOXY]ACETIC ACID SUBSTITUTED-ALPHA TO THE OXAZOLE RING, Journal of medicinal chemistry, 36(24), 1993, pp. 3871-3883
NONPROSTANOID PROSTACYCLIN MIMETICS .5. STRUCTURE-ACTIVITY-RELATIONSHIPS ASSOCIATED WITH 4,5-DIPHENYL-2-OXAZOLYL)-5-OXAZOLYL]PHENOXY]ACETICACID
Authors: MEANWELL NA ROMINE JL ROSENFELD MJ MARTIN SW TREHAN AK WRIGHT JJK MALLEY MF GOUGOUTAS JZ BRASSARD CL BUCHANAN JO FEDERICI ME FLEMING JS GAMBERDELLA M HARTL KS ZAVOICO GB SEILER SM
Citation: Na. Meanwell et al., NONPROSTANOID PROSTACYCLIN MIMETICS .5. STRUCTURE-ACTIVITY-RELATIONSHIPS ASSOCIATED WITH 4,5-DIPHENYL-2-OXAZOLYL)-5-OXAZOLYL]PHENOXY]ACETICACID, Journal of medicinal chemistry, 36(24), 1993, pp. 3884-3903
Risultati: 1-8 |